Zoekresultaten - 11 results
Impact of substance type and patient characteristics on the choice of treatment setting for substance use disorder in Belgium
was used to study all patients’ orientation toward both sectors, across all treatment episodes (n = 29,658). Results: The study found that the primary substance significantly influences sector choice. ...
De TDI-registratie in België- Jaarlijks rapport, registratiejaar 2023
aanzienlijk toe in alle drie de gewesten van het land. • De vraag naar behandeling voor ketamine, mephedrone en methamfetamine blijft aanzienlijk stijgen in België. Daarentegen is de vraag naar behandeling voor ...
Full Characterisation of Heroin Samples Using Infrared Spectroscopy and Multivariate Calibration
therefore 125 heroin samples were collected directly from users and analysed with classical chromatographic techniques. Further, MidInfrared spectra were collected for all samples, to be used in Partial Least ...
Applying and implementing future-oriented methods on a national level; towards enhanced policy and service preparedness to threats in the drugs domain
SO. All countries in Europe are recommended to become well prepared in terms of monitoring and responses. In order to support that process a set of implementation guides on effectively respond to ...
Which drugs of choice are on the rise or in decline? A trend analysis of Belgium’s treatment settings (2015-2019)
increase in cocaine treatment demands in Western Europe, all emphasise the importance of monitoring the use and harms of drugs over time. To be informed about new consumption patterns, this study aims to ...
Reitox national reporting to EMCDDA on drugs and drug addiction, 2020
mandate, the EMCDDA relies on the collaboration with the European information network (Reitox), consisting of all national drug observatories in the EU Member state plus Turkey, Norway and the European ...
All-cause mortality rate of people in treatment for substance use disorders in Belgium: A register-based cohort study
Keywords: all-cause Belgium mortality substance use disorder Treatment Demand Indicator Health Topics: Illegale drugs Ziekten en gezondheid in kaart brengen Illicit drugs Drogues illégales Health and disease ...
General practice patients treated for substance use problems: a cross-national observational study in Belgium.
(SGP) in 2013. Baseline (at the first encounter) and 7-month follow-up data were reported of all patients treated for substance use problems. Two main measurements were type of substance use and patient ...
Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol.
objective of the paper is to facilitate the use of data by authorities or researchers by correctly describing all aspects of the indicator. The case definition, the variables collected and the way data should ...
Reitox national reporting to EMCDDA on drugs and drug addiction, 2021
drug addiction in Europe. In order to fulfil the above, the EMCDDA relies on the collaboration with the European information network (Reitox), consisting of all national drug observatories in the EU ...